Biology of Platelet-Derived Growth Factor and Its Involvement in Disease
- 1 September 2006
- journal article
- review article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 81 (9), 1241-1257
- https://doi.org/10.4065/81.9.1241
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trialThe Lancet, 2004
- SU6668 in idiopathic myelofibrosis – A rational therapeutic approach targeting several tyrosine kinases of importance for the myeloproliferation and the development of bone marrow fibrosis and angiogenesisMedical Hypotheses, 2003
- Inflammation and cancerNature, 2002
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsThe New England Journal of Medicine, 2002
- PDGF receptor kinase blocker AG1295 attenuates interstitial fibrosis in rat kidney after unilateral obstructionCell and tissue research, 2000
- Rapid disruption of gap junctional communication and phosphorylation of connexin43 by platelet-derived growth factor in T51B rat liver epithelial cells expressing platelet-derived growth factor receptorJournal of Cellular Physiology, 1998
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994
- The CUB Domain: A Widespread Module in Developmentally Regulated ProteinsJournal of Molecular Biology, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- PDGF AA homodimers are potent chemoattractants for fibroblasts and neutrophils, and for monocytes activated by lymphocytes or cytokinesBiochemical and Biophysical Research Communications, 1992